Obesity and COVID-19: The Two Sides of the Coin

. 2020 ; 13 (4) : 430-438. [epub] 20200713

Jazyk angličtina Země Švýcarsko Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid32659766

The World Health Organization declared COVID-19, the infectious disease caused by the coronavirus SARS-CoV-2, a pandemic on March 12, 2020. COVID-19 is causing massive health problems and economic suffering around the world. The European Association for the Study of Obesity (EASO) promptly recognised the impact that the outbreak could have on people with obesity. On one side, emerging data suggest that obesity represents a risk factor for a more serious and complicated course of COVID-19 in adults. On the other side, the health emergency caused by the outbreak diverts attention from the prevention and care of non-communicable chronic diseases to communicable diseases. This might be particularly true for obesity, a chronic and relapsing disease frequently neglected and linked to significant bias and stigmatization. The Obesity Management Task Force (OMTF) of EASO contributes in this paper to highlighting the key aspects of these two sides of the coin and suggests some specific actions.

Department of Clinical Science University of Bergen Bergen Norway

Department of Endocrinology and Nutrition Clínica Universidad de Navarra University of Navarra IdiSNA CIBEROBN Spanish Health Institute Carlos 3 Pamplona Spain

Department of Human Biology NUTRIM School of Nutrition and Translational Research in Metabolism Maastricht University Medical Centre Maastricht The Netherlands

Department of Internal Medicine D and Obesity Clinic Hasharon Hospital Rabin Medical Center Petah Tikva Sackler School of Medicine Tel Aviv University Tel Aviv Israel

Department of Medicine University of Padova Padova Italy

Department of Public Health and Preventive Medicine Faculty of Medicine in Pilsen Charles University Pilsen Czechia

Department of Public Health Faculty of Health Sciences Ben Gurion University of the Negev Be'er Scheva Israel

Division of Endocrinology Metabolism and Diabetes Department of Medicine Istanbul University Cerrahpasa Medical Faculty Istanbul Turkey

European Association for the Study of Obesity Teddington United Kingdom

Obesity Prevention and Care Program Contrepoids Service of Therapeutic Education for Chronic Diseases Department of Community Health Primary Care and Emergency Geneva University Hospitals and University of Geneva Geneva Switzerland

School of Physiotherapy Division of Population Health Sciences Royal College of Surgeons in Ireland Dublin Ireland

School of Psychology University of Leeds Leeds United Kingdom

Technological and Educational Institute of Thessaloniki School of Food Technology and Nutrition Department of Nutrition Thessaloniki Greece

Komentář v

PubMed

Zobrazit více v PubMed

Frühbeck G, Baker JL, Busetto L, Dicker D, Goossens GH, Halford JC, et al. European Association for the Study of Obesity Position Statement on the Global COVID-19 Pandemic. Obes Facts. 2020;13((2)):292–6. PubMed PMC

Liu PP, Blet A, Smyth D, Li H. The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation. 2020 Jul;142((1)):68–78. PubMed

Sattar N, McInnes IB, McMurray JJ. Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms [Online ahead of print.] Circulation. 2020 Jul;142((1)):4–6. PubMed

Honce R, Schultz-Cherry S. Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol. 2019 May;10:1071. PubMed PMC

Kanneganti TD, Dixit VD. Immunological complications of obesity. Nat Immunol. 2012 Jul;13((8)):707–12. PubMed

Luzi L, Radaelli MG. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic. Acta Diabetol. 2020 Jun;57((6)):759–64. PubMed PMC

Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M, et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome [Online ahead of print.] J Thromb Haemost. 2020 Jul;18((7)):1747–51. PubMed PMC

Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. LICORN and the Lille COVID-19 and Obesity study group High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation [Online ahead of print.] Obesity (Silver Spring) 2020 Jul;28((7)):1195–9. PubMed PMC

Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. ISARIC4C investigators Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020 May;369:m1985. PubMed PMC

Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission [Online ahead of print.] Clin Infect Dis. 2020 Apr;:ciaa415. PubMed PMC

Busetto L, Bettini S, Fabris R, Serra R, Dal Pra' C, Maffei P, et al. Obesity and COVID-19: an Italian snapshot [Online ahead of print.] Obesity (Silver Spring) 2020 10.1002/oby.22918 [online ahead of print] PubMed PMC

Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical Characteristics of Covid-19 in New York City [Online ahead of print.] N Engl J Med. 2020 Jun;382((24)):2372–4. PubMed PMC

Ryan DH, Ravussin E, Heymsfield S. COVID 19 and the Patient with Obesity - The Editors Speak Out. Obesity (Silver Spring) 2020 May;28((5)):847. PubMed PMC

Meschi S, Selleri M, Lalle E, Bordi L, Valli MB, Ferraro F, et al. Duration of viral shedding in hospitalized patients infected with pandemic H1N1. BMC Infect Dis. 2011 May;11((1)):140. PubMed PMC

Kim YH, Kim JK, Kim DJ, Nam JH, Shim SM, Choi YK, et al. Diet-induced obesity dramatically reduces the efficacy of a 2009 pandemic H1N1 vaccine in a mouse model. J Infect Dis. 2012 Jan;205((2)):244–51. PubMed

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020 May;130((5)):2620–9. PubMed PMC

Abrams EM, Szefler SJ. COVID-19 and the impact of social determinants of health [Online ahead of print.] Lancet Respir Med. 2020 May 18;8((7)):659–61. PubMed PMC

Alberga AS, Edache IY, Forhan M, Russell-Mayhew S. Weight bias and health care utilization: A scoping review. Prim Health Care Res Dev. 2019;20(e116):e116. PubMed PMC

Sutin AR, Stephan Y, Terracciano A. Weight Discrimination and Risk of Mortality. Psychol Sci. 2015 Nov;26((11)):1803–11. PubMed PMC

Ramos Salas X, Kirk S, Alberga A, Forhan M, Russell-Mayhew S, Cameron E, Nutter S, Sharma AM. Obesity Canada's EveryBODY Matters Collaborative Weight bias, obesity stigma and COVID-19. Obesity Canada website [ https://obesitycanada.ca/oc-news/weight-bias-obesity-stigma-and-covid-19/] accessed June 4, 2020.

Sutin AR, Robinson E, Daly M, Gerend MA, Stephan Y, Luchetti M, et al. Body Mass Index, Weight Discrimination, and Psychological, Behavioral, and Interpersonal Responses to the Coronavirus Pandemic [Online ahead of print.] Obesity (Silver Spring) 2020 May 23; 10.1002/oby.22914 [online ahead of print] PubMed PMC

Frühbeck G, Busetto L, Dicker D, Yumuk V, Goossens GH, Hebebrand J, et al. The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications. Obes Facts. 2019;12((2)):131–6. PubMed PMC

Tsigos C, Hainer V, Basdevant A, Finer N, Mathus-Vliegen E, Micic D, et al. Obesity Management Task Force of the European Association for the Study of Obesity Criteria for EASO-collaborating centres for obesity management. Obes Facts. 2011;4((4)):329–33. PubMed PMC

WHO Library Cataloguing-in-Publication Data . Telemedicine: opportunities and developments in Member States: report on the second global survey on eHealth 2009. Global Observatory for eHealth Series, 2: Who, Geneva; 2020.

Rubino F, Cohen RV, Mingrone G, le Roux CW, Mechanick JI, Arterburn DE, et al. Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery [Online ahead of print.] Lancet Diabetes Endocrinol. 2020 Jul;8((7)):640–8. PubMed PMC

Gupte M, Boustany-Kari CM, Bharadwaj K, Police S, Thatcher S, Gong MC, et al. ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. Am J Physiol Regul Integr Comp Physiol. 2008 Sep;295((3)):R781–8. PubMed PMC

Park SM, Kwak YS, Ji JG. The effects of combined exercise on health-related fitness, endotoxin, and immune function of postmenopausal women with abdominal obesity. J Immunol Res. 2015;2015:830567. PubMed PMC

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Body Mass Index and Risk for COVID-19-Related Hospitalization in Adults Aged 50 and Older in Europe

. 2022 Sep 27 ; 14 (19) : . [epub] 20220927

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...